viewBushveld Minerals Limited

Bushveld Minerals fired up by soaring vanadium price

Revenues climbed to US$192mln (US$3mln), while pre-tax profits rocketed to US$86.6mln compared to a loss of US$900,000.

Vanadium toughens steel for high stress uses

Vanadium miner Bushveld Minerals PLC (LON:BMN) saw its sales and revenues soar in 2018 as the price of the steel additive shot higher.

The metal is also seen as a potential electrolyte for batteries and excitement over this application, coupled with supply issues in China helped the price jump by 149% over the year.

WATCH: Bushveld Minerals 'in a very strong position' despite weaker Vanadium price

Even though production at the Vametco mine eased slightly to 2,560 metric tonnes, Bushveld's revenues climbed to US$192mln (US$3mln), while pre-tax profits rocketed to US$86.6mln compared to a loss of US$900,000.

Power storage is a key area for Bushveld, which is working with South Africa’s state power utility Eskom to develop a workable vanadium redox battery.

Since the year-end, the company also announced the US$68mln acquisition of Vanchem, which has processing capability in South Africa and is a specialist in vanadium-based compounds.

Fortune Mojapelo, Bushveld's chief executive, said: "Following the refurbishment programme at Vanchem and the expansion programme underway at Vametco, the company will have created a portfolio of processing assets capable of supplying approximately 10% of the global vanadium market.

“This was acquired for less than 40% of the estimated US$500mln replacement cost and used cash generated by the same assets for nearly half (US$100mln) of the cost of creating that capacity.”

Bushveld also said while it was not paying a dividend in 2018, going forward it would consider payments based on free cash-flow.

Quick facts: Bushveld Minerals Limited

Price: 20.82 GBX

Market: LSE
Market Cap: £232.99 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bushveld Minerals Limited named herein, including the promotion by the Company of Bushveld Minerals Limited in any Content on the Site, the...



Investor Update: hVIVO’s mosquito vaccine moves into the clinic

Headlines from the Proactive Investors UK newsroom.  Clinical services group hVIVO’s (LON:HVO) experimental vaccine AGS-v PLUS is to undergo a phase 1 safety trial at the University of Maryland school of medicine. The vaccine is designed to protect against mosquito-borne diseases such as...

on 31/7/19

2 min read